Short answer: Myo-inositol is one form of inositol, a compound naturally present in the body and in some foods that participates in cellular signaling pathways. It is used in supplements aimed at women, and researchers have studied it particularly in polycystic ovary syndrome (PCOS). However, the evidence is not strong enough to consider it a fertility treatment or a substitute for medication.
What is inositol?
Inositols are a group of compounds structurally similar to sugars. Myo-inositol is the most common form in the body and plays roles in intracellular signaling and pathways related to insulin response, among other functions.
Why is myo-inositol studied in women with PCOS?
Because insulin resistance and metabolic disturbances are common in many women with polycystic ovary syndrome, inositol has been studied as a supplement that might influence some metabolic and hormonal markers.
The 2023 international evidence-based guideline for PCOS states that inositol may be considered according to a patient’s preferences and values, with possible improvement in some metabolic measures, but clinical benefits for ovulation, hirsutism and weight are limited.
Is there an officially recommended type or dose?
There is currently no specific dose or formulation that international guidelines can confidently prefer. The same guideline notes that the quality of evidence is insufficient to recommend a particular type, dose or combination for adults and adolescents with PCOS.
This is important when comparing products: a larger number on the pack does not automatically make a product better or appropriate for everyone.
What do recent systematic reviews say?
A systematic review and meta-analysis published in 2024 examined 30 trials involving more than 2,000 participants. Results suggested possible benefits for some metabolic measures, but the researchers described the overall evidence as limited and inconclusive, with findings varying according to the comparison and outcome measured.
For this reason, myo-inositol is better viewed as a supplement that can be discussed as part of a broader plan rather than as a guaranteed stand-alone solution.
Is myo-inositol a fertility treatment?
It should not be presented that way. International guidelines consider inositol use in women with PCOS and infertility to be experimental because evidence for ovulation, clinical pregnancy and live birth remains limited and uncertain.
How should you read a myo-inositol supplement label?
- Check the amount of myo-inositol in the daily serving, not in the whole package.
- Review other ingredients such as vitamins or minerals instead of focusing on one ingredient alone.
- Follow the directions on the packaging.
- Tell your doctor or pharmacist which supplements you use, especially if you have PCOS, are receiving fertility treatment or take regular medicines.
- Do not stop a prescribed medicine in favor of a supplement without professional advice.
Example: Inomeri
When reviewing Inomeri, read the amount of myo-inositol and the other nutrients per sachet and daily serving as officially stated, then compare them with your individual needs and professional guidance. The presence of myo-inositol does not mean the product is a medicine for treating PCOS or infertility.
Key takeaway
Myo-inositol has been studied relatively extensively in PCOS, and there are indications of possible metabolic benefits for some women. However, the quality of evidence does not support fixed promises, there is no strong recommendation for one specific type or dose, and it should not be regarded as a proven infertility treatment. The best decision depends on diagnosis, individual goals, diet and medicines being used.
Sources
- 2023 International Evidence-based Guideline for PCOS
- Fitz et al., 2024 — Inositol for PCOS: systematic review and meta-analysis
Notice: This content is for general education and is not a diagnosis or treatment. If you have menstrual irregularities or symptoms of PCOS, or are planning a pregnancy, consult a doctor or qualified healthcare professional.